BSE - Delayed Quote INR

Marksans Pharma Limited (MARKSANS.BO)

Compare
194.50
-13.95
(-6.69%)
At close: April 9 at 3:42:44 PM GMT+5:30

Research Analysis

Revenue vs. Earnings

Revenue 6.82B
Earnings 1.05B

Q4'23

Q2'24

Q3'24

Q4'24

0
2B
4B
6B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

265.00
299.33 Average
194.50 Current
323.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----22
Avg. Estimate 008.5510.7
Low Estimate 008.310.7
High Estimate 008.810.7
Year Ago EPS ----6.928.55

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
No. of Analysts ----22
Avg. Estimate ----26.15B30.39B
Low Estimate ----26.12B30.05B
High Estimate ----26.19B30.74B
Year Ago Sales ----21.77B26.15B
Sales Growth (year/est) ----20.12%16.21%

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Current Estimate 008.5510.7
7 Days Ago 008.5310.7
30 Days Ago 008.5310.7
60 Days Ago 008.7510.83
90 Days Ago 008.7510.83

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days ----11
Down Last 30 Days ----11

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
MARKSANS.BO ----23.55%25.15%
S&P 500 6.43%6.13%9.43%14.26%